Skip to main content
Clinical Trials/CTRI/2024/01/061186
CTRI/2024/01/061186
Not yet recruiting
Phase 4

Comparative Evaluation of concentrated growth factor with platelet rich fibrin for the treatment of infrabony defects- A randomized controlled study. - Nil

Dr Angela Johnson0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr Angela Johnson
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Angela Johnson

Eligibility Criteria

Inclusion Criteria

  • 1\.Systemically healthy Participants diagnosed with localized or generalized Stage II/III
  • periodontitis within the age group of 18\-50 years.
  • 2\. Participants with at least one tooth with probing depth (PPD) \> 5mm and presence of
  • infrabony component (IC) \>3mm site after phase I therapy.

Exclusion Criteria

  • 1\. Pregnant and lactating women
  • 2\. Medications which interfere with platelet
  • function within last three months and
  • antibiotics taken within 1 month prior to
  • 3\. Patients with systemic disease.
  • 4\. History of Smoking or tobacco consumption.
  • 5\. Patients with poor oral hygiene or previous
  • lack of cooperation with the maintenance

Outcomes

Primary Outcomes

Not specified

Similar Trials